Fasting-based estimates of insulin sensitivity in overweight and obesity: a critical appraisal. (Q51492652)

5 April 2018

title

Fasting-based estimates of insulin sensitivity in overweight and obesity: a critical appraisal. (English)

1 reference

5 April 2018

0 references

5

Ele Ferrannini

1 reference

5 April 2018

author name string

Johannes B Ruige

1

1 reference

5 April 2018

Ilse L Mertens

2

1 reference

5 April 2018

Ellen Bartholomeeusen

3

1 reference

5 April 2018

Eveline Dirinck

4

1 reference

5 April 2018

Luc F Van Gaal

6

1 reference

5 April 2018

publication date

1 July 2006

1 reference

5 April 2018

published in

Obesity

1 reference

5 April 2018

volume

14

1 reference

5 April 2018

issue

7

1 reference

5 April 2018

page(s)

1250-1256

1 reference

5 April 2018

Insulin and risk of cardiovascular disease: a meta-analysis.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Statistical methods for assessing agreement between two methods of clinical measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

The meaning and use of the area under a receiver operating characteristic (ROC) curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Epidemiology of insulin resistance and its relation to coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Epidemic Obesity and the Metabolic Syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Serum true insulin concentration and the risk of clinical non-insulin dependent diabetes during long-term follow-up.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Insulin resistance is related to silent cerebral infarction in patients with essential hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Evaluation of insulin sensitivity in clinical practice and in research settings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

The assessment of insulin resistance in man.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Correlation of oral glucose tolerance test-derived estimates of insulin sensitivity with insulin clamp measurements in an African-American cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Revised QUICKI provides a strong surrogate estimate of insulin sensitivity when compared with the minimal model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Determinants of postabsorptive endogenous glucose output in non-diabetic subjects. European Group for the Study of Insulin Resistance (EGIR).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Insulin action and age. European Group for the Study of Insulin Resistance (EGIR).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Diagnosing insulin resistance in the general population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Impact of degree of obesity on surrogate estimates of insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

TRIPOD (TRoglitazone In the Prevention Of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Monthly intra-individual variation in lipids over a 1-year period in 22 normal subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

Report of the American Diabetes Association's Task Force on standardization of the insulin assay

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.142

31 March 2020

Identifiers

DOI

10.1038/OBY.2006.142

1 reference

5 April 2018

PubMed ID

16899806

1 reference

5 April 2018